Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)

计划入组 26 人 · 首次发布于 2014 年 9 月 25 日

CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies

计划入组 12 人 · 首次发布于 2025 年 8 月 6 日

CD180 Overexpression in Follicular Lymphoma

计划入组 184 人 · 首次发布于 2016 年 12 月 1 日

Camelid-derived anti-CD18 antibodies (Johns Hopkins University)

RP-L201

CD184-Dasatinib-ADC(Ambrx)

Groundbreaking Gene Therapy Gives New Life to Boy with "Death Sentence" Immune Disease

Gene Therapy Shows Promising Results in Children with Rare Immune Disorder LAD-I

Cellenkos Receives FDA Fast Track Designation for CK0803 in Amyotrophic Lateral Sclerosis